Symmetry Investments’s Ocugen OCGN Stock Holding History

Symmetry Investments’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-15,000	Closed	-$24.6K	–	227
2024 Q1	$24.6K	Buy	+15,000	New	+$12.6K	﹤0.01%	169

Other funds holding OCGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Symmetry Investments's OCGN Position: Q2 2024 in Review

Symmetry Investments sold out of Ocugen (OCGN) in Q2 2024, closing a stake of 15,000 shares — an estimated $24.6K sold.

Symmetry Investments first reported a position in OCGN in Q1 2024 and held it in 1 quarter. The position peaked at $24.6K in Q1 2024. 101 funds tracked by Wall St. Rank hold OCGN as of Q2 2024.

Symmetry Investments reported no remaining Ocugen position as of Q2 2024 after selling out during the quarter.
Symmetry Investments sold 15,000 Ocugen shares in Q2 2024, an estimated $24.6K.
Symmetry Investments first reported a position in Ocugen in Q1 2024 and held it in 1 quarter.
Symmetry Investments's Ocugen position peaked at $24.6K in Q1 2024.
101 funds tracked by Wall St. Rank held Ocugen as of Q2 2024.

Based on Symmetry Investments's 13F filing for Q2 2024, filed 13 Aug 2024.